Annals of Pediatric Endocrinology & Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Seungah Lee, Dong Yun Lee

Ann Pediatr Endocrinol Metab. 2017;22(1):15-26. Published online March 31, 2017
DOI: https://doi.org/10.6065/apem.2017.22.1.15

Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development

Bo Ahrén

Journal of Diabetes Investigation. 2018;

Link1 Link2

Glucagon-like peptide-1 receptor agonists

Baptist Gallwitz

Handbook of Incretin-based Therapies in Type 2 Diabetes. 2016;31-43

Link1

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association

Hyun Jin Kim

The Journal of Korean Diabetes. 2018;19(1):35

Link1 Link2 Link3

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes

Gagik R. Galstyan, Evgeniya A. Karataeva, Ekaterina A. Yudovich

Diabetes mellitus. 2017;20(4):286-298

Link1 Link2

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Seungah Lee, Dong Yun Lee

Annals of Pediatric Endocrinology & Metabolism. 2017;22(1):15

Link1 Link2 Link3

Glucagon-like peptide-1 receptor agonists and their effects on weight reduction

Shyi-Jang Shin

Journal of Diabetes Investigation. 2012;3(6):490-491

Link1

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

K. B. Hansen, F. K. Knop, J. J. Holst, T. Vilsbøll

International Journal of Clinical Practice. 2009;63(8):1154-1160

Link1

Emerging New Therapies for the Treatment of Type 2 Diabetes Mellitus: Glucagon-like Peptide-1 Receptor Agonists

Christopher A. Lindamood, James R. Taylor

Clinical Therapeutics. 2015;37(3):483-493

Link1 Link2

Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus

Young Min Cho, Rhonda D. Wideman, Timothy J. Kieffer

Endocrinology and Metabolism. 2013;28(4):262

Link1 Link2 Link3

The role of glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Erin St Onge, Shannon Miller, Elizabeth Clements, Lindsay Celauro, Ke’la Barnes

Journal of Translational Internal Medicine. 2017;5(2):79-89

Link1 Link2